| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PRIMA-1-Met | CTRPv2 | pan-cancer | AAC | 0.063 | 0.2 |
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | -0.054 | 0.2 |
| mRNA | navitoclax:birinapant (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.044 | 0.2 |
| mRNA | Bosutinib | FIMM | pan-cancer | AAC | -0.42 | 0.2 |
| mRNA | CCT036477 | CTRPv2 | pan-cancer | AAC | -0.04 | 0.3 |
| mRNA | Nutlin-3a (-) | GDSC1000 | pan-cancer | AAC | 0.039 | 0.3 |
| mRNA | Pyrimethamine | GDSC1000 | pan-cancer | AAC | 0.062 | 0.3 |
| mRNA | JNK Inhibitor VIII | GDSC1000 | pan-cancer | AAC | -0.04 | 0.3 |
| mRNA | BRD9647 | CTRPv2 | pan-cancer | AAC | -0.044 | 0.3 |
| mRNA | TL-2-105 | GDSC1000 | pan-cancer | AAC | -0.037 | 0.3 |